| Literature DB >> 28702015 |
Tansol Park1, Tea Meulia2, Jeffrey L Firkins1, Zhongtang Yu1.
Abstract
Axenic cultures of free-living aerobic ciliates, such as Tetrahymena thermophila and Paramecium aurelia, have been established and routinely used in laboratory research, greatly facilitating, or enabling characterization of their metabolism, physiology, and ecology. Ruminal protozoa are anaerobic ciliates, and they play important roles in feed digestion and fermentation. Although, repeatedly attempted, no laboratory-maintainable axenic culture of ruminal ciliates has been established. When axenic ciliate cultures are developed, antibiotics are required to eliminate the accompanying bacteria. Ruminal ciliates gradually lose viability upon antibiotic treatments, and the resultant axenic cultures can only last for short periods of time. The objective of this study was to evaluate eight antibiotics that have been evaluated in developing axenic cultures of ruminal ciliates, for their toxicity to Entodinium caudatum, which is the most predominant ruminal ciliate species. Scanning and transmission electron microscopy (TEM) showed that the antibiotics damaged both the cell surface and nuclei of E. caudatum and increased accumulation of intracellular glycogen. Combinations of the three least toxic antibiotics failed to eliminate the bacteria that are present in the E. caudatum culture. The combination of ampicillin, carbenicillin, streptomycin, and oxytetracycline was able to eliminate all the bacteria, but the resultant axenic E. caudatum culture gradually lost viability. Adding the bacterial fraction (live) separated from an untreated E. caudatum culture reversed the viability decline and recovered the growth of the treated E. caudatum culture, whereas feeding nine strains of live bacteria isolated from E. caudatum cells, either individually or in combination, could not. Nutritional and metabolic dependence on its associated bacteria, accompanied with direct and indirect inhibition by antibiotics, makes it difficult to establish an axenic culture of E. caudatum. Monoxenic or polyxenic cultures of E. caudatum could be developed if the essential symbiotic partner(s) can be identified.Entities:
Keywords: Entodinium; antibiotics; associated bacteria; axenic culture; ruminal protozoa
Year: 2017 PMID: 28702015 PMCID: PMC5487518 DOI: 10.3389/fmicb.2017.01189
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
List of all antibiotics used in this study.
| Ampicillin (Sigma, A9518) | 50 mg/ml in H2O | 0.1–2 mg/ml | Cell wall | Gram (+), (−) | Bactericidal |
| Streptomycin (Sigma, S9137) | 25 mg/ml in H2O | 0.1–2 mg/ml | Aminoglycoside, 30S protein synthesis | Gram (+), (−) | Bactericidal |
| Carbenicillin (Sigma, C3416) | 50 mg/ml in H2O | 0.1–2 mg/ml | Cell wall | Gram (+), (−) | Bactericidal |
| Tetracycline (Sigma, T3383) | 50 mg/ml in H2O | 0.03–0.3 mg/ml | 30S protein synthesis | Gram (+), (−) | Bacteriostatic |
| Neomycin (Sigma, N6910) | 50 mg/ml in H2O | 0.1–1 mg/ml | Aminoglycoside, 30S protein synthesis | Gram (+), (−) | Bactericidal |
| Bacitracin (Sigma, B5150) | 50 mg/ml in 1N HCl | 0.05–1 mg/ml | Cell wall | Gram (+) | Bactericidal |
| Normocin™ (InvivoGen) | Commercial | 0.05–0.5 mg/ml | 50S protein synthesis + DNA synthesis + disrupting ionic exchange through cell membrane (yeast & fungi) | Gram (+), (−) Fungi | Bactericidal |
| Chloramphenicol (Sigma, C0378) | 50 mg/ml in ethanol | 0.005–0.05 mg/ml | 50S protein synthesis | Gram (+), (−) | Bacteriostatic |
Based on Gottlieb and Shaw, .
Literature review about previous research on establishing axenic culture of protozoa and algae.
| Low bacterial contamination (103–104 bacteria/ml) | Penicillin (1,400 U/ml) Streptomycin sulfate (570 μg/ml) Dihydrostreptomycin (570 μg/ml) Neomycin sulfate (570 μg/ml) | Coleman, | ||
| Enabled inhibition of growth completely; no growth was seen up to 10 days | These axenic protozoa could be kept alive in the presence of dead bacterial cells for up to 3 weeks, but their growth was extremely slow | Carbenicillin (500 μg/ml) Aminobenzylpenicillin (500 μg/ml) Cephaloridine (500 μg/ml) Chloramphenicol (100 μg/ml) Leucomycin (100 μg/ml) | Hino and Kametaka, | |
| Cellulolytic Flagellate | Axenic status after 2 passages (in 30 days) | Penicillin (1,000 U/ml) = 600 μg/ml Streptomycin (1 mg/ml) | Yamin, | |
| Axenic culture was maintained (Migration + adaptation medium plus antibiotics) | The ciliates can be maintain in the growth medium | Penicillin (100 U/ml), Streptomycin (100 μg/ml), and fungizone (0.25 μg/ml) | Allen and Nerad, | |
| Low bacterial contamination levels | Cell-free extract of mixed rumen bacteria adsorbed on activated charcoal was relieved the stress of low bacterial contamination | 50 μg/ml each of streptomycin, penicillin and chloramphenicol and sulphadrug | Onodera and Henderson, | |
| Axenic culture (confirmed through SEM) | Established in axenic culture using the TYI-S-33 medium | Bacitracin (50 μg/ml) Gentamicin (100 μg/ml) Penicillin (25 U/ml) Streptomycin (25 μg/ml) Amphotericin B (0.06 μg/ml) | Erlandsen et al., | |
| The antibiotic solution effectively killed more than 99% of the bacteria in 4 h (bacterial counts using MPN) | Much better growth with live bacteria | Approximately, Penicillin (1250 U/ml) Streptomycin (81.25 U/ml) | Fondevila and Dehority, | |
| Marine microalga | Removal of bacteria was accomplished using a mixture of 5 antibiotics (axenic after 3 days incubation) | Similar growth with reference culture | Ampicillin (500 μg/ml) Gentamycin (100 μg/ml) Kanamycin (200 μg/ml) Neomycin (1 mg/ml) Streptomycin (100 μg/ml) | Cho et al., |
| Rumen ciliates: | No PCR amplification of bacterial or archaeal 16S rRNA gene from the culture supernatant (48 h incubation) | Over 90% was maintained after 48 h with antibiotics mixture | Penicillin G potassium (100 μg/ml) Streptomycin sulfate (100 μg/ml) Kanamycin sulfate (100 μg/ml) 5-Fluorocytosine (50 μg/ml) Chloramphenicol (3.2 μg/ml) | Irbis and Ushida, |
| Axenic culture | – | Neomycin (100 μg/ml), Kanamycin (100 μg/ml), Tetracycline (100 μg/ml) Normocin™(2 μl/ml) Normocin™, Penicillin (250 μg/ml), Streptomycin (250 μg/ml) Three-fold of Normocin™(6 μl/ml) | Cassidy-Hanley, |
E. caudatum data (% of that of the control) in the presence of different antibiotics (mg/ml).
| 12080a | 19395a | 19999a | 1440 | ||||
| 0.1 | 0.83 | 0.47ab | 0.52ab | 0.12 | <0.0001 | <0.0001 | 0.0066 |
| 0.5 | 0.84 | 0.01b | 0.01b | 0.14 | |||
| 1 | 0.83 | 0.43ab | 0b | 0.13 | |||
| 2 | 0.85 | 0.63a | 0.47ab | 0.06 | |||
| – | Q | L | |||||
| 0.1 | 0.82 | 1.03a | 1.11a | 0.07 | <0.0001 | 0.257 | 0.0031 |
| 0.5 | 0.95 | 0.89a | 0.98ab | 0.03 | |||
| 1 | 0.69 | 0.55b | 0.76b | 0.05 | |||
| 2 | 0.88 | 0.49b | 0.42 | 0.08 | |||
| – | L | L | |||||
| 0.1 | 0.83 | 0.64b | 0.85a | 0.04 | <0.0001 | <0.0001 | 0.0004 |
| 0.5 | 0.87 | 0.45b | 0.43b | 0.07 | |||
| 1 | 0.93 | 0.56b | 0.44b | 0.08 | |||
| 2 | 0.78 | 0.49b | 0.28b | 0.08 | |||
| Contrast | - | L | L | ||||
| 0.03 | 0.94 | 0.58b | 0.2b | 0.11 | <0.0001 | <0.0001 | 0.0001 |
| 0.05 | 0.87 | 0.49bc | 0.23b | 0.1 | |||
| 0.1 | 0.88 | 0.55b | 0.17b | 0.11 | |||
| 0.3 | 0.81 | 0.24c | 0.03b | 0.12 | |||
| Contrast | - | L | L | ||||
| 0.1 | 0.85 | 0.75b | 0.96a | 0.04 | <0.0001 | <0.0001 | 0.0011 |
| 0.3 | 0.84 | 0.53bc | 0.51b | 0.06 | |||
| 0.6 | 0.76 | 0.51c | 0.37b | 0.06 | |||
| 1 | 0.74 | 0.42c | 0.33b | 0.07 | |||
| Contrast | L | L | L | ||||
| 0.05 | 0.89ab | 0.72ab | 0.56b | 0.07 | <0.0001 | <0.0001 | 0.0514 |
| 0.1 | 0.93ab | 0.58b | 0.5b | 0.08 | |||
| 0.5 | 0.71ab | 0.54b | 0.4b | 0.05 | |||
| 1 | 0.49b | 0.07c | 0.01c | 0.08 | |||
| Contrast | L | L | L | ||||
| 0.05 | 0.89ab | 0.65b | 0.56b | 0.06 | <0.0001 | <0.0001 | 0.2012 |
| 0.1 | 0.69ab | 0.47bc | 0.57b | 0.04 | |||
| 0.3 | 0.69ab | 0.39bc | 0.31c | 0.07 | |||
| 0.5 | 0.5b | 0.18c | 0.1c | 0.08 | |||
| Contrast | L | L | L | ||||
| 0.005 | 0.82a | 0.11b | 0.08b | 0.13 | <0.0001 | <0.0001 | <0.0001 |
| 0.01 | 0.76ab | 0b | 0b | 0.13 | |||
| 0.03 | 0.71ab | 0b | 0b | 0.12 | |||
| 0.05 | 0.39b | 0b | 0b | 0.07 | |||
| L | L | L | |||||
The final concentrations of antibiotics were in mg/ml. Different superscripts (a–c) in the same column denote significant difference (P < 0.05) in the proportion of protozoa cell counts between the control and each antibiotic treatment. Significance (
, P ≤ 0.01;
, P ≤ 0.05;
, P ≤ 0.10) of linear (L) and quadratic (Q) contrast are shown. Each value was the mean of three replicates. A, antibiotics; T, incubation time.
Correlation between protozoal cell counts and optical density (OD) of antibiotics-treated E. caudatum cultures (n = 3).
| Overall | 0.14 | 0.0167 |
| Ampicillin | 0.30 | 0.0421 |
| Streptomycin | −0.11 | 0.4752 |
| Carbenicillin | 0.66 | <0.0001 |
| Tetracycline | 0.62 | <0.0001 |
| Neomycin | 0.64 | <0.0001 |
| Bacitracin | −0.51 | 0.0003 |
| Normocin™ | 0.57 | <0.0001 |
| Chloramphenicol | 0.80 | <0.0001 |
Figure 1Scanning electron micrograph of E. caudatum cells maintained in the in vitro cultures before (A) and after (B) filtration and washing. The in vitro cultures did not receive any antibiotics. The scale bars = 10 μm.
Figure 2Transmission electron micrographs of E. caudatum cells that were not exposed to antibiotics. (A), longitudinal section; (B), a dividing microbial cell in the endoplasm (pointed by the arrow); (C), amplified view of the dividing microbe; and (D), a microbial cell being degraded/digested.
Figure 3Scanning electron micrograph of E. caudatum cells in the antibiotics-treated cultures (after 48 h incubation). The micrograph of non-treated E. caudatum cells was shown in Figure 1. (A) ampicillin (0.5 mg/ml); (B) streptomycin (2 mg/ml); (C) carbenicillin (2 mg/ml); (D) tetracycline (0.3 mg/ml); (E), neomycin (1 mg/ml); (F) bacitracin (1 mg/ml); (G) Normocin™ (0.5 mg/ml); and (H) chloramphenicol (0.005 mg/ml). The scale bars = 5 μm.
Figure 4(A) Micronucleus (MIC) and macronucleus (MAC) in the ectoplasm of an E. caudatum cell that was not treated with any antibiotics. Both chromatin (electron dense dark areas) and granular nucleoli (gray areas) were visible in both the MIC and MAC. MAC and increased number of glycogen granules upon treatment with 1 mg/ml carbenicillin (B) and 0.1 mg/ml Normocin™ (C) for 48 h. The scale bars = 1 μm.
Figure 5Accumulation of glycogen granules (electron lucent bodies) in E. caudatum cells treated with carbenicillin (1 mg/ml) for 24 h (A) and Normocin™ (0.1 mg/ml) for 48 h (B). The scale bars = 2 μm.
Figure 6The average area of glycogen granules per longitudinally sectioned E. caudatum cell. Five largest granules were selected from each treatment and measured. Ctrl, untreated E. caudatum cells; CB, carbenicillin (1 mg/ml) treated cells; NM, Normocin™ (0.1 mg/ml) treated cells. The treatment cultures were incubated in the presence of each antibiotic for 24 or 48 h, while the control culture received no antibiotics and was incubated for 48 h. Error bars represent SEM (n = 5). *, significant difference (P < 0.05) between the control and the treatments, but not among the treatments
Figure 7TEM micrographs of the cortex of E. caudatum cells. (A) untreated E. caudatum cells; (B) carbenicillin (1 mg/ml, for 48 h) treated cells; (C) Normocin™ (0.1 mg/ml, 24 h) treated cells. External filamentous glycocalyx (arrows) covering the cortical layers of E. caudatum cells showed morphological disparity between antibiotics-treated and untreated cells. The scale bars = 500 nm.
Figure 8Effect of carbenicillin alone and its combination with bacitracin and neomycin and growth factors on E. caudatum cell counts. = control without any antibiotics; = carbenicillin (1 mg/ml); = combination of carbenicillin and bacitracin (0.05 mg/ml); = combination of carbenicillin and neomycin (0.1 mg/ml); = combination of carbenicillin, bacitracin, and neomycin. (A), no addition of growth factors; (B), addition of 1% [v/v] fetal bovine serum, 1 μg/ml [w/v] stigmasterol, 0.767 μM heminm and 0.005% [w/v] bovine serum albumin. Erros bars SEM (n = 3).
Figure 9Effect of adding live bacteria (isolated from the E. caudatum culture) to the growth of temporarily axenic cultures of E. caudatum. (A) daily feeding with the mixed bacterial fraction from the culture of E. caudatum (not treated with any antibiotics); (B) daily feeding with single bacterial isolates from a washed non-antibiotic treated E. caudatum culture (average of feeding three bacterial isolates); (C) daily feeding of a combination of three bacteria isolated from a washed non-antibiotic treated E. caudatum culture; (D) control without daily feeding of any live bacteria.